GILD - Gilead completes CymaBay acquisition but negative impact on 2024 EPS
2024-03-22 17:37:29 ET
More on Gilead Sciences
- Gilead Sciences Finally Starts Succeeding
- Gilead Sciences: Realizing Financial Projections Is Key
- Gilead Sciences, Inc. (GILD) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Dividend Roundup: Qualcomm, Amgen, AIG, Gilead Sciences, and more
- Gilead, Merck once weekly combo HIV therapy shows promise in phase 2